The improved survival rate and cost-effectiveness of a 7-day continuous subcutaneous insulin infusion set

A global perspective on the issue of access to insulin

(2021) David Beran et al.   DIABETOLOGIA

The High Cost of Insulin in the United States: An Urgent Call to Action

(2020) S. Vincent Rajkumar   MAYO CLINIC PROCEEDINGS

Changing costs of type 1 diabetes care among US children and adolescents

(2020) Stephanie Crossen et al.   PEDIATRIC DIABETES

A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control

(2020) Delia Waldenmaier et al.   Diabetes Technology & Therapeutics

994-P: Clinical Study of a New Extended Wear Infusion Set

(2020) JACOB ILANY et al.   DIABETES

1167-P: CSII and Insulin: Does Extending the Wear Duration of Infusion Sets Save Expensive Insulin?

(2020) SARNATH CHATTARAJ et al.   DIABETES

Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025

(2020) Xiling Lin et al.   Scientific Reports

Impact of Insulin Injection and Infusion Routines on Lipohypertrophy and Glycemic Control in Children and Adults with Diabetes

(2019) Asma Deeb et al.   Diabetes Therapy

Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes

(2019) Johan Jendle et al.   Diabetes Technology & Therapeutics

Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review

(2019) Martina Vettoretti et al.   Biomedical Engineering Online

Reduced medical spending associated with increased use of a remote diabetes management program and lower mean blood glucose values

(2019) Christopher M. Whaley et al.   JOURNAL OF MEDICAL ECONOMICS

WITHDRAWN: IDF Diabetes Atlas: Worldwide Estimates of Incidence, Prevalence and Mortality of Type 1 Diabetes in Children and Adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

(2019) Christopher C. Patterson et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Estimated Lifetime Economic Burden of Type 1 Diabetes

(2019) Matthew Sussman et al.   Diabetes Technology & Therapeutics

Economic Costs of Diabetes in the U.S. in 2017

(2018)   DIABETES CARE

Health Care Utilization and Burden of Diabetic Ketoacidosis in the U.S. Over the Past Decade: A Nationwide Analysis

(2018) Dimpi Desai et al.   DIABETES CARE

Preserving Skin Integrity with Chronic Device Use in Diabetes

(2018) Laurel H. Messer et al.   Diabetes Technology & Therapeutics

Emerging Technologies for Diabetes Care

(2018) Timothy S. Bailey et al.   Diabetes Technology & Therapeutics

The cost of diabetes and obesity in Australia

(2018) Crystal Man Ying Lee et al.   JOURNAL OF MEDICAL ECONOMICS

Is insulin pump therapy effective in Type 1 diabetes?

(2018) J. C. Pickup   DIABETIC MEDICINE

Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study

(2018) Christopher C. Patterson et al.   DIABETOLOGIA

Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial

(2018) Wen Wan et al.   MEDICAL DECISION MAKING

Cost-Related Insulin Underuse Among Patients With Diabetes

(2018) Darby Herkert et al.   JAMA Internal Medicine

Insulin analogues in type 1 diabetes mellitus: getting better all the time

(2017) Chantal Mathieu et al.   Nature Reviews Endocrinology

Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis

(2016) Gary A. Puckrein et al.   DIABETES CARE

Improving Patient Experience With Insulin Infusion Sets

(2016) Alison B. Evert et al.   DIABETES EDUCATOR

Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes

(2016) Andrew W. Karlin et al.   Diabetes Technology & Therapeutics

Expenditures and Prices of Antihyperglycemic Medications in the United States: 2002-2013

(2016) Xinyang Hua et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review

(2015) S. Roze et al.   DIABETIC MEDICINE

Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a UK perspective

(2015) Stéphane Roze et al.   JOURNAL OF MEDICAL ECONOMICS

Trends in Incidence of Type 1 Diabetes Among Non-Hispanic White Youth in the U.S., 2002–2009

(2014) Jean M. Lawrence et al.   DIABETES

Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation

(2014) E Cummins et al.   HEALTH TECHNOLOGY ASSESSMENT

Randomized Trial of Infusion Set Function: Steel Versus Teflon

(2013) Parul J. Patel et al.   Diabetes Technology & Therapeutics

Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects

(2013) Jim McCambridge et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy

(2009) Daniela Bruttomesso et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS